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As a member of the normal human oral microbiota, the fungus Candida albicans is
often found in association with Streptococcus gordonii, a member of dental plaque
forming bacteria. Evidence suggests that S. gordonii serves as a facilitator of C. albicans
adherence to dental tissues, which represents a clinically relevant problem, particularly
for immunocompromised individuals that could subsequently develop fungal infections.
In this study we describe the development of a relatively simple and economical in vitro
model that allows for the growth of mixed bacterial/fungal biofilms in 96-well microtiter
plates. We have applied this method to test and compare the growth characteristics
of single and dual species biofilms in traditional microbiological media versus a
synthetic saliva medium (basal medium mucin, BMM) that more closely resembles
physiological conditions within the oral cavity. Results indicated a synergistic effect for
the formation of biofilms when both microorganisms were seeded together under all
conditions tested. The structural and architectural features of the resulting biofilms were
further characterized using scanning electron microscopy and confocal scanning laser
microscopy. We also performed drug susceptibility assays against single and mixed
species biofilms using commonly used antifungals and antibacterial antibiotics, both in
monotherapy and in combination therapy, for a direct comparison of resistance against
antimicrobial treatment. As expected, mixed species biofilms displayed higher levels of
resistance to antimicrobial treatment at every dose tested in both traditional media and
BMM synthetic saliva, as compared to single-species biofilms.
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INTRODUCTION
Candida albicans is an opportunistic pathogenic fungus able to colonize and cause infections
in a variety of host sites, including the oral cavity. As such, candidiasis represents the most
common oral fungal infection affecting mostly immunosuppressed patients, denture wearers and
the elderly (Muzyka, 2005; Meurman and Hamalainen, 2006; Muzyka and Epifanio, 2013). Oral
sites that C. albicans is able to colonize and subsequently cause infection include mucosal surfaces,
Frontiers in Microbiology | www.frontiersin.org 1 May 2016 | Volume 7 | Article 686
fmicb-07-00686 May 12, 2016 Time: 14:57 # 2
Montelongo-Jauregui et al. Mixed Biofilms on Synthetic Saliva
periodontal pockets, root canals, enamel, dentures and ortho-
dontic appliances (Ramage et al., 2004; de Carvalho et al.,
2006; Arslan et al., 2008; Dongari-Bagtzoglou et al., 2009; Sardi
et al., 2010; Freitas et al., 2014). Most frequently oral candidiasis
is associated with the formation of C. albicans biofilms,
leading to high levels of resistance to antimicrobial therapy
and providing protection against the host’s immune system,
thus further complicating treatment (Hawser and Douglas,
1995; Williams et al., 2011; Mathe and Van Dijck, 2013). In
recent years there has been an increased recognition of the
complexity of these biofilms, which often are polymicrobial
in nature as a result of the interactions between C. albicans
and members of the oral bacterial microbiome (Hwang
et al., 2015; Jakubovics, 2015; O’Donnell et al., 2015a,b; Wu
et al., 2015). Streptococci of the mitis group, most notably
Streptococcus gordonii, are among the early colonizers and
comprise a large proportion of the oral microbiota, and
the ability of C. albicans to interact with oral streptococci
and form biofilm consortia in multiple oral sites has been
documented (Jenkinson et al., 1990; Bamford et al., 2009;
Silverman et al., 2010; Falsetta et al., 2014; Jakubovics
et al., 2014; Xu et al., 2014; Chukkapalli et al., 2015).
These interactions are bidirectional and considered to be
mutualistic beneficial, leading to a cooperative relationship that
greatly contributes to survival, persistence and pathogenicity
of these microorganisms in diverse oral niches (Jenkinson
et al., 1990; Waltimo et al., 1997; O’Sullivan et al., 2000;
Lana et al., 2001; Jenkinson and Douglas, 2002; Holmes
et al., 2006; Shirtliff et al., 2009; Morales and Hogan,
2010).
A variety of in vitro models have been developed and used to
study and characterize mixed fungal/bacterial biofilms. Virtually
all these models use traditional nutrient-rich microbiological
media that have been optimized for either bacterial or fungal
growth (Jenkinson et al., 1990; Holmes et al., 1995; Bamford
et al., 2009; Jarosz et al., 2009; Silverman et al., 2010; Ishijima
et al., 2012). In the present study we grew C. albicans/S. gordonii
polymicrobial biofilms utilizing a synthetic saliva medium [basal
medium mucin (BMM)] to more closely mimic physiological
conditions found by these microorganisms within the oral cavity.
Our goal was to study the morphological and architectural
characteristics, as well as the antifungal susceptibility profiles
associated with mixed oral C. albicans/S. gordonii biofilms grown
in this artificial saliva medium as compared to those formed using
traditional microbiological media.
MATERIALS AND METHODS
Composition and Preparation of BMM
Synthetic Saliva Medium
Preparation of BMM synthetic saliva followed the protocol from
Wong and Sissons (Wong and Sissons, 2001), and consists of the
following: 2.5 g partially purified pig gastric mucin, 5 g protease
peptone (PP), 5 g yeast extract (YE), 33.5 mmol KCl, 2.5 mg
haemin, 1 mg menadione, 1 mmol urea, and 1 mmol arginine
diluted in a liter of Millipore water and sterilized in an autoclave.
Strains and Growth Conditions
The strains of microorganisms used were C. albicans wild-type
strain SC5314 and S. gordonii wild-type strain Challis DL1.1.
C. albicans was regularly cultured on yeast peptone dextrose
(YPD) agar plates aerobically at 37◦C. C. albicans suspension
cultures were routinely grown in 20 ml of YPD medium in
an orbital shaker (150–180 rpm) at 28◦C overnight. Cells were
harvested by centrifugation (5000 × g, 5 min) the supernatant
was removed and the pellet washed with sterile PBS followed by
vortexing cells and centrifugation (two times), then resuspended
in the desired media for biofilm growth and counted using a
hemocytometer. Dilutions were made to obtain a final suspension
of 1.0 × 106 cells/ml in the corresponding medium, to be seeded
for biofilm formation in the wells of microtiter plates (see below).
Streptococcus gordonii was regularly cultured on Tryptone
Soy Agar with 5% sheep blood plates, anaerobically inside of a
CO2 incubator. Suspension cultures of S. gordonii were grown
in 20 ml of Todd-Hewitt Broth + 0.02% w/v Yeast Extract
(THB + 0.02% YE) media, without shaking inside a 5% CO2
incubator for 16 h at 37◦C. After 16h incubation, 100 µl from
the suspension culture were aspirated and inserted into 10 ml of
fresh THB+ 0.02% YE media and shaken in orbital shaker (150–
180 rpm) for 3 h at 37◦C. Bacterial cells were then harvested by
centrifugation (5000 × g, 5 min), the supernatant was removed
and the pellet washed with sterile PBS followed by vortexing cells
and centrifugation (two times). Bacterial cell concentrations were
calculated measuring OD600 with a spectrophotometer. Finally,
dilutions were performed in order to obtain a final concentration
of 1.0× 107 cells/ml in desired media for growth of biofilms (see
below).
Drugs
A stock solution of fluconazole (Hospira, Lake Forest, IL, USA)
prepared in sodium chloride for injection at 2 mg/ml was
obtained and stored at 4◦C until used. Amphotericin B was
obtained in solution at 250 µg/ml (Gibco Life Technologies,
Grand Island, NY, USA) and stored at −20◦C until used.
Caspofungin (Merck and Co., Inc., Whitehouse Station, NJ, USA)
was obtained as a powder and was stored at 4◦C; a stock solution
was prepared in PBS at 2 mg/ml the same day before its addition
to well plates. Clindamycin (RPI, Corp., Prospect, IL, USA) was
obtained as a powder; a stock solution was prepared in de-ionized
water at 10 mM and stored at 4◦C until used.
Biofilm Formation in 96-Well Microtiter
Plates
One hundred µl of the prepared dilutions with single or mixed
microorganisms (1 × 106 cells/ml for C. albicans, 1 × 107
cells/ml for S. gordonii) in RPMI 1640, THB + 0.02% YE,
1:1 v/v RPMI/ THB + 0.02% YE media or BMM Synthetic
Saliva were pipetted into each well of a 96-well (flat bottom)
microtiter plate (Corning R© Incorporated, Corning, NY, USA).
The selected cell concentrations were based on previous reports
on polymicrobial biofilms (Harriott and Noverr, 2009; Cugini
et al., 2010; Diaz et al., 2012; Filkins et al., 2015). The plates
were then incubated for 24 h inside a 5% CO2 incubator
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at 37◦C. After incubation, the supernatant was removed and
samples were washed twice with 100 µl PBS. PBS was aspirated
and the viability of cells within the biofilms was estimated by
adding 100 µl of 1:10 v/v Presto BlueTM Cell Viability Reagent
(InvitrogenTM, Carlsbad, CA, USA) in 1:1 v/v RPMI/ THB +
0.02% YE media and incubated for 30 min inside a 5% CO2
incubator at 37◦C. Finally, 80 µl from each well were transferred
into a new 96-well plate for fluorescent readings. The microtiter
plate reader (BioTek R© SynergyTM HT, Winoosky, VT, USA) was
set to measure fluorescence at 530/25 nm excitation and 590/35
emission.
Kinetic Studies on the Formation of
Mixed Biofilms on 96-Well Microtiter
Plates
After seeding fungal and bacterial cells on 96-well microtiter
plates (as described above), samples were collected every 4 h for a
period of 24 h, in triplicates. Plates were washed twice with PBS.
Cell viability was measured by adding 100 µl of 1:10 v/v Presto
BlueTM as described above.
Bright-Field Microscopy
One hundred µl of crystal violet solution (0.6 g crystal violet
prepared in 10 ml isopropanol, 10 ml methanol, 180 ml Millipore
water) were added to wells containing the biofilms and removed
after 1 min. Excess stain was removed by washing biofilms once
with PBS. Samples were directly observed on the 96-well plate
using a 40x objective in an inverted system microscope (Westover
Scientific, Mill Creek, WA, USA) equipped for photography.
The images were processed for display using Micron software
(Westover Scientific).
Scanning Electron Microscopy
For scanning electron microscopy (SEM), biofilms were grown
in 6-well plates (Corning R©) with 6 ml of C. albicans at 1 × 106
cell/ml, S. gordonii at 1 × 107 cell/ml or mixed at the same final
cellular concentrations and incubated in a 5% CO2 incubator
for 24 h at 37◦C. Biofilms were then fixed with a solution of
glutaraldehyde (2.5% [wt/vol])-0.1 M sodium calcodylate buffer
at pH 7.4 for 2 h at 37◦C. Following fixation, the samples
were treated with osmium tetroxide solution (1% [wt/vol])-
0.1 M sodium calcodylate buffer at pH 7.4 for 2 h at room
temperature. Samples were then rinsed with water and washed
in a graded series of ethanol solutions (a step gradient of 30,
50, 70, and 90% in water for 10 min per step) ending with
100% ethanol. Before visualization, samples were dried overnight
in a vacuum dryer and subsequently coated with a 60:40 gold-
palladium alloy, with an approximate thickness of 883 Å using
a sputter coater. Samples were observed using a JEOL JSM-6610
Scanning Electron Microscope (JEOL USA, Inc., Peabody, MA,
USA). The images were processed for display using Photoshop
software (Adobe, Mountain View, CA, USA).
Confocal Scanning Laser Microscopy
Biofilms were grown using 6-well plates (same as for SEM) and
incubated in a 5% CO2 incubator for 24 h at 37◦C. For confocal
scanning laser microscopy (CSLM), biofilms were stained in the
dark in the following order: at 37◦C for 30 min with 25 µg/ml
concavalin A-Alexa Fluor R© 488 conjugate (Molecular Probes,
Eugene, OR, USA), at room temperature for 30 min with 1X
FilmTracerTM SYPRO R© Ruby Biofilm Matrix Stain (Molecular
Probes), and for 10 min at 37◦C with 300 nM 4′,6-diamidino-2-
phenylindole, dihydrochloride (DAPI, Molecular Probes). After
incubation the supernatant was removed and the biofilms rinsed
with 2 ml of PBS to remove non-adhered cells. Lastly, biofilms
were gently washed with PBS for removal of excess stain. Samples
were viewed using a LSM 510 upright confocal microscope
(Carl Zeiss, Thornwood, NY, USA) with an Achroplan 63x-oil
objective, using excitation/emission wavelengths of 358/461 nm
for blue fluorescence, 495/519 nm for green fluorescence and
450/610 nm for red fluorescence. Pictures were analyzed using
AutoQuant X2 (Media Cybernetics, Rockville, MD, USA);
additionally 3-D images were made using IMARIS 6.4 software
(Bitplane, St. Paul, MN, USA). The images were processed for
display using Photoshop software (Adobe, Mountain View, CA,
USA). Production of exopolymeric matrix material was estimated
using image processing software Fiji by measuring intensity of the
red color in the confocal images (Schindelin et al., 2012).
In Vitro Biofilm Antifungal Susceptibility
Testing
For biofilm inhibition assays, cell cultures were processed
as mentioned previously but the final concentrations for
microorganisms were prepared at C. albicans at 3 × 106 cell/ml
and for S. gordonii at 3 × 107 cell/ml for S. gordonii in
1:1 v/v RPMI/ THB + 0.02% YE media and BMM Synthetic
Saliva. Then 33.3 µl of the prepared cell dilutions of single
and mixed microorganisms were pipetted into each well of
a 96-well microtiter plate. For monotherapy assays, 33.3 µl
of media of choice (1:1 v/v RPMI/ THB + 0.02% YE media
or BMM Synthetic Saliva), finally, 33.3 µl of drug solutions
at different concentrations were pipetted into the desired
wells. Positive controls were no drug control (only medium
of choice and cells), and negative controls were wells where
cells within the biofilms had been killed with 33.3 µl of 10%
Triton R© X-100 (Fisher Bioreagents R©, Fair Lawn, NJ, USA). For
combination therapy (antifungals plus clindamycin), 33.3 µl of
the prepared cell dilutions of single and mixed microorganisms
were pipetted into each well, plus 33.3 µl of antifungal (diluted
in either 1:1 v/v RPMI/ THB + 0.02% YE media or BMM
Synthetic Saliva), along with 33.3 µl of Clindamycin solution
(diluted in either 1:1 v/v RPMI/THB + 0.02% YE media
or BMM Synthetic Saliva) at desired concentrations. Final
concentrations tested for each drug were: Fluconazole at 0.5,
0.25, 0.125, 0.0625, and 0.03125 mg/ml; Amphotericin B at 16,
4, 1, 0.25, and 0.06 µg/ml; Caspofungin at 16, 8, 4, 2, and
1 µg/ml; and Clindamycin at 100, 10, 1, 0.1, and 0.01 µM.
After incubation for 24 h, microtiter plates were washed and
processed using the Presto BlueTM assay as described above.
From these results, sessile minimum inhibitory concentration
(SMIC) values for each drug were determined at both 50 and 80%
inhibition.
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Antimicrobial susceptibility testing was also performed by
adding drugs at desired concentrations to preformed single and
mixed species biofilms grown in different media (1:1 v/v RPMI/
THB + 0.02% YE media or BMM Synthetic Saliva), which
were then incubated for an additional 24 h in the presence
of drugs. Briefly, wells of microtiter plates were seeded with
microorganisms and incubated for 24 h to allow for biofilm
formation. Drugs were diluted in either 1:1 v/v RPMI/ THB
+ 0.02% YE media or BMM Synthetic Saliva and added to
the preformed biofilms (after washings) at the following final
concentrations: Fluconazole at 1, 0.5, 0.25, 0.125, 0.0625 mg/ml;
Amphotericin at B 16, 4, 1, 0.25, 0.0625µg/ml; Caspofungin at 16,
8, 4, 2, 1µg/ml and Clindamycin at 100, 10, 1, 0.1, 0.01µM. After
incubation for an additional 24 h, microtiter plates were washed
and processed using the Presto BlueTM assay as described above.
Additionally, SMIC values for each drug were determined at both
50% and 80% inhibition against preformed biofilms.
Statistics
Viability assays of single and dual-species biofilms were
performed with 11 replicates for each growth condition assessed.
The data was analyzed using Prism (GraphPad, La Jolla, CA,
USA) and the differences were considered statistically significant
if P < 0.05 by one-way ANOVA test. Dunnett’s multiple
comparison was performed considering RPMI 1640 as the
medium of reference for C. albicans biofilms; THB + 0.02%
YE for S. gordonii biofilms; and 1:1 mixture of RPMI 1640
and THB + 0.02% YE for mixed biofilms; for comparison
against all other growth media, and differences were considered
statistically significant if P < 0.05. Biofilm kinetic studies were
performed in triplicate for each sample type at every time point.
Drug susceptibility assays were performed in triplicate, data was
normalized with respect to the average of 6 positive control
samples (no drug sample) considered as 100%, and the average
of 6 negative control samples (treated with 10% Triton X-100),
considered as 0%. For each sample the average of 3 replicates was
subtracted by the average of the positive controls, and divided by
the difference of positive and negative controls, finally multiplied
by a 100 ((Sample average- POS Average)/(POS Average-NEG
Average))∗100.
RESULTS
Growth Characteristics of C. albicans
and S. gordonii Single and Dual Species
Biofilms in Synthetic Saliva as Compared
with Traditional Microbiological Media
We used a 96-well microtiter plate model for biofilm formation
to study single and mixed-species biofilm development in BMM
synthetic saliva as compared to traditional laboratory media. For
comparison purposes, RPMI 1640 media was chosen for biofilm
growth as it is widely used for the formation of C. albicans
biofilms, and similarly, THB+ 0.02% YE media is conventionally
used for growth of Streptococci biofilms (Loo et al., 2000;
Pierce et al., 2008). In order to give a fair advantage to both
microorganisms to grow within a dual species biofilm, we also
tested a mixture of RPMI 1640 and THB + 0.02% YE at a 1:1
ratio. Metabolic activity of the cells within the resulting biofilms
was measured using Presto BlueTM, which is able to measure
viability of both bacterial and fungal microorganisms (Deepe and
Buesing, 2012; Potapova et al., 2013). The Presto BlueTM reagent
was used in a 1:10 dilution of 1:1 media, to keep consistency
between both cell types, regardless of growth as a mono- or dual-
species biofilm.
As expected in the case of monospecies biofilms, the use of
microorganism-specific media (RPMI for C. albicans and THB
+ 0.02% YE for S. gordonii) resulted in the production of highly
proliferative mono-species biofilms with increased readouts
for metabolic activity for the corresponding microorganism.
(Figures 1A,B). Similarly, of all media tested, a 1:1 mixture of
RPMI 1640 and THB + 0.02% YE as well as THB + 0.02% YE
resulted in the most robust generation of mixed fungal/bacterial
biofilms (Figure 1C). This was also expected, as this media
combination should support the growth of both cell types. These
results permitted us to consider RPMI 1640 as the medium
of reference for C. albicans biofilms, THB + 0.02% YE as the
medium of reference for S. gordonii biofilms and the 1:1 mixture
of RPMI 1640 and THB + 0.02% YE as the medium of reference
for mixed biofilms for further statistical analyses (Figures 1A–C).
The use of non-species specific media (i.e., bacterial media for
C. albicans and fungal media for S. gordonii) resulted in less
robust biofilms (Figures 1A,B). P < 0.05 Dunnett’s test. The
extent of biofilm formation by C. albicans grown in 1:1 mixture
of RPMI 1640 and THB + 0.02% YE resulted in intermediate
values compared to those obtained using either RPMI 1640 or
THB + 0.02% YE media alone (Figure 1A). P < 0.05 Dunnett’s
test. S. gordonii biofilms on the other hand, had similar growth
in both specific medium THB + 0.02% YE and 1:1 mixture
of RPMI 1640 and THB + 0.02% YE, while they grew poorly
in both RPMI 1640 and BMM synthetic saliva (Figure 1B).
P ≥ 0.05 Dunnett’s test. In mixed biofilms, higher metabolic
readings when directly compared to single species biofilms grown
in the same type of media (Figures 1A–C) seem to point to
synergistic interactions between bacterial and fungal cells. As
expected, 1:1 media mixture yielded the most robust (highest
metabolic activity) dual-species biofilms. However, interestingly
when mixed species biofilms were grown in THB+ 0.02% YE, in
theory favoring S. gordonii growth, results indicated comparable
viability readings to those grown in 1:1 media (Figure 1C).
P≥ 0.05 Dunnett’s test. This suggests that S. gordonii is capable of
supporting C. albicans growth in a not so favorable environment
for the fungus when grown together with the bacterium, also
pointing to synergistic interactions. As seen in Figure 1, for
both single- and mixed-species biofilms formed using BMM
synthetic saliva, readings of metabolic activity were generally
lower compared to similar biofilms formed using traditional
microbiological media, and this was particularly noticeable in
the case of S. gordonii single species biofilms. However, we
note that mixed biofilms formed in synthetic saliva displayed
metabolic activity similar to those formed in RPMI medium, and
demonstrated a synergistic effect as compared to their mono-
species counterparts (compare Figures 1C to 1A,B). Overall,
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FIGURE 1 | Extent of biofilm formation in different media as assessed by metabolic activity after 24 h incubation for single species Candida albicans
(A), Streptococcus gordonii (B), and mixed-species (C) biofilms. Biofilms were grown in RPMI 1640, THB + 0.02% YE, 1:1 v/v RPMI/ THB + YE or BMM
synthetic saliva (BMM) in 96-well microtiter plates for 24 h. Viability was measured by Presto Blue R© fluorescence Error bars represent standard deviations. Data was
analyzed by Dunnett’s multiple comparison test, considering RPMI 1640 as the medium of reference for C. albicans biofilms; THB + YE for S. gordonii biofilms; and
1:1 mixture of RPMI 1640 and THB + 0.02% YE for mixed biofilms. ∗ represents statistically significant differences as compared to the medium of reference
P < 0.05.
FIGURE 2 | Kinetic study of single and mixed species biofilms of C. albicans and S. gordonii grown in 1:1 v/v RPMI/ THB + 0.02% YE media (A) and
BMM synthetic saliva (BMM; B). Cell viability was estimated at 4 h intervals for 24 h using Presto BlueTM fluorescence. Each time point was estimated in
triplicates. Error bars represent standard deviations. P-values obtained using One-way ANOVA analysis of variance between the three groups (each biofilm type
taken as a group). Statistically significant difference between groups is represented by P < 0.05.
these data indicates that BMM synthetic saliva supports biofilm
formation by the two microorganisms, although to a lesser
extent than traditional microbiological media. Also, results are
indicative of synergistic interactions between fungal and bacterial
cells leading to the formation of more robust mixed-species
biofilms.
In a second set of experiments, we performed a series of
biofilm kinetic studies to examine formation of both single and
mixed species biofilms over a period of time, using both 1:1
media and BMM synthetic saliva. As shown in Figures 2A,B,
the metabolic activity of C. albicans biofilms progressively
increases during formation, reaching its peak at 20 h with a
slight reduction observed at 24 h in both media and synthetic
saliva, thereby indicating maturation. On the other hand, the
metabolic activity of S. gordonii single-species biofilms is higher
at earlier time points (4–12 h), which corresponds with a
highly proliferative phase of biofilm development, and gradually
reduces at later time points under both growing conditions
(Figures 2A,B). Also as shown in Figure 2, in both 1:1 media
mixture (Figure 2A), and BMM synthetic saliva (Figure 2B) the
fluorometric readings for dual-species biofilms are considerably
higher than those for single species biofilms at most time
points. Of note, in the case of synthetic saliva the metabolic
activity of mixed fungal-bacterial biofilms was higher than
the sum of each organism individually, particularly during
intermediate and late stages of biofilm development, clearly
pointing to a synergistic effect. These results were analyzed
using One-way ANOVA analysis which demonstrates that single
and mixed species kinetics are statistically different, highlighting
synergism in mixed species biofilms. Microscopic observations
indicated that both single species biofilms colonized the bottom
of the wells at a similar rate and demonstrate comparable
confluency in both media conditions (Supplementary Figure S1).
Bright-field microscopy also allowed us to observe a somewhat
distinct shape of C. albicans filaments when biofilms were
grown in BMM synthetic saliva, which appeared more curvy-
like filaments with flaccid appearance (hairy-like) as compared
to those formed in media displaying more typical morphological
features (Supplementary Figure S1A). S. gordonii was able to
develop biofilms under both conditions, forming aggregates of
cells across the surface (Supplementary Figure S1B). Consistent
with metabolic readings, in mixed biofilms total confluency of
cells within the wells was reached at around 12 h of incubation,
with high interspecies clustering observed particularly as a result
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FIGURE 3 | Scanning electron microscopy (SEM) observations of single species and dual-species C. albicans/S. gordonii biofilms grown in 1:1 v/v
RPMI/ THB + 0.02% YE media (upper panel) and BMM synthetic saliva (SS, lower panel).
FIGURE 4 | Characterization of mixed C. albicans/S. gordonii biofilms using CSLM and 3D-reconstruction software. Mixed biofilms grown in 1:1 v/v
RPMI/ THB + 0.02% YE media (upper panel) or BMM synthetic saliva (BMM, lower panel). Biofilms were stained with Concavalin A – Alexa Fluor 488 fungal cell wall
stain (green), DAPI nucleic acid stain (blue) and FilmTracerTM Sypro R© Ruby biofilm matrix stain (red), Numbers at bottom right corner of the picture represent
approximate biofilm thickness measured using AutoQuant X2 software.
of S. gordonii accumulation and binding to C. albicans filaments
(Supplementary Figure S1C).
Structural Characteristics of Biofilms
Formed in BMM Synthetic Saliva as
Compared to Those Formed in
Traditional Media
To analyze the morphological, structural and architectural
characteristics and differences between biofilms developed in
both media types, we grew biofilms on 6-well plates and
visualized them using SEM and CSLM (Figures 3 and 4).
Scanning electron microscopy observations revealed that
mono-species biofilms formed by C. albicans under both media
conditions showed predominantly filamentous cells; however,
visualization of terminal blastospores and interspersed yeast cells
seemed more prevalent in biofilms grown in BMM synthetic
saliva, perhaps due to a somewhat lower density of the hyphal
mat as compared to biofilms grown in 1:1 medium (Figure 3,
Supplementary Figures S2A,B). Particularly noticeable was the
fact that S. gordonii biofilms formed in BMM synthetic saliva
showed long streptococcal chains, as compared to densely packed
clumps observed in biofilms formed using 1:1 media (Figure 3
and Supplementary Figures S2C,D). As expected mixed biofilms
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demonstrated a greater degree of complexity, with the SEM
images demonstrating the close interactions between bacterial
and fungal cells reflected in high interspecies clustering. In 1:1
media, the biofilms showed highly dense areas of streptococcal
cells forming thickly packed aggregates binding to fungal
cells. The long chains of streptococcal cells formed in BMM
synthetic saliva were found binding predominantly binding to
C. albicans hyphal elements (Figure 3, Supplementary Figures
S2E,F). Overall, SEM observations confirmed that, even though
significantly lower metabolic activity was detected for biofilms
grown in BMM synthetic saliva (Figures 1A–C), both fungal
and bacterial cells are able to form dense, robust biofilms on the
polystyrene surface in synthetic saliva.
Confocal scanning laser microscopy observations confirmed
the SEM results and allowed for a more detailed characterization
of the main architectural features and three-dimensional
characteristics of the mono- and dual-species biofilms under
these two conditions (Figure 4 and Supplementary Figure S3).
Mono-species biofilms formed by C. albicans were thicker in
1:1 media compared to BMM synthetic saliva, although biofilms
formed in the latter medium demonstrated a higher cellular
density along with high production of exopolymeric material,
seen in red (Supplementary Figure S3A). S. gordonii biofilms are
much thinner than those formed by C. albicans; but they also
exhibit increased production of exopolymeric matrix material
when grown in BMM synthetic saliva (Supplementary Figure
S3B). It is important to mention that a key component of
BMM synthetic saliva is mucin, which can bind to Concavalin
A, therefore explaining the green fluorescence seen in this
sample S. gordonii biofilms (Supplementary Figure S3B). Mixed
biofilms grown on BMM synthetic saliva are relatively thicker
(∼50 µm) compared to biofilms developed on 1:1 media
(∼30 µm), and longer hyphae according to the confocal images
obtained (Figure 4). We note that Presto Blue R© fluorometric
readings are higher in the case of mixed biofilms grown on
1:1 media, thus potentially indicating lower metabolic activity
of sessile cells within the mixed biofilms formed using BMM
synthetic saliva despite their increased thickness and density.
Furthermore, DAPI and Concanavalin A staining confirmed the
previous observations in bright-field microscopy and SEM of
streptococcal cells binding to C. albicans filaments in mixed
biofilms.
Effect of Antimicrobial Monotherapy and
Combination Therapy against Single and
Mixed Species Biofilms Formed in BMM
Synthetic Saliva and Traditional
Microbiological Media
Increased antimicrobial resistance represents one of the
hallmarks of the biofilm mode of growth, with important clinical
consequences, and the formation of polymicrobial biofilms can
complicate the treatment of this type of infections (Jenkinson
and Douglas, 2002; Peters et al., 2012). Once the model was fully
developed, we performed a series of experiments to examine
the efficacy of antimicrobial treatment against the resulting
biofilms. These included monotherapy and combination therapy
(antifungal plus antibacterial antibiotics) against both single-
species and dual species biofilms of C. albicans/S. gordonii formed
using either synthetic saliva or 1:1 mixed media, and using two
different treatment modalities: prevention of biofilm formation
and activity against preformed biofilms (Figure 5). We used
clindamycin and three common antifungal agents. Clindamycin
was used, as it is an antibiotic active against gram-positive
bacteria and commonly used for the treatment of streptococcal
disease, including oral infections (Parks et al., 2015), whereas the
antifungals used for these assays were fluconazole, amphotericin
B and caspofungin, representatives of each of the major classes of
clinically-used antifungals (azoles, polyenes, and echinocandins,
respectively; Pfaller, 2012; Pierce et al., 2013). Using the afore-
mentioned antifungals in monotherapy for the inhibition
of C. albicans biofilms proved to be highly effective in 1:1
media (Figure 5A, upper panel) and BMM synthetic saliva
(Figure 5A, lower panel). Likewise, inhibition of S. gordonii
biofilm formation was effectively achieved at the higher doses
of Clindamycin tested in these experiments in both media
used (100 and 10 µM; Figure 5). As expected, we observed
much lower levels of inhibition of mixed C. albicans/S. gordonii
biofilms using each of the antimicrobials alone (monotherapy
modality) irrespective of the growth medium used (Figure 5A).
Supplementary Table S1 summarizes the resulting SMIC50 and
SMIC80 values for each drug tested in monotherapy experiments
against both single- and dual-species biofilm formation.
Using combinatorial treatment, that is adding antifungals plus
clindamycin to prevent the formation of mixed biofilms, there
was a more effective inhibition of biofilm formation, particularly
at the higher doses tested of both drugs, with caspofungin plus
clindamycin showing the highest degree of inhibition than any
other drug combination (Figure 5B). This is particularly
noticeable when considering physiological/therapeutic
concentrations for each of the antifungals employed in this
study, as due to the known recalcitrance of biofilms to azoles,
the fluconazole concentrations used are in the mg/ml range and
considered to be suprapharmacological. Moreover, although
somewhat subtle, for all antifungal/antibacterial combinations
we observed a trend of increased resistance for mixed biofilms
formed in BMM synthetic saliva as compared to traditional
media (Figure 5B, lower panel). These results demonstrate that
the association of C. albicans and S. gordonii in dual species
biofilms can complicate efforts to prevent biofilm formation,
possibly resulting in the development of disease.
We also investigated the activity of antibacterial and antifungal
antibiotics, either alone or in combination, against single and
dual-species preformed biofilms (Figure 6). Consistent with
previous observations (Pierce et al., 2013), C. albicans preformed
biofilms displayed increased resistance to antifungal treatment.
These fungal biofilms were susceptible to monotherapy with
caspofungin at all concentrations tested (16, 8, 4, 2, and
1 µg/ml). Amphotericin B displayed good activity at high
doses (16, 4, 1 µg/ml), although we note that these doses are
relatively high and generally considered toxic (Pierce et al., 2013).
Preformed fungal biofilms show intrinsic resistance to azoles,
and as expected fluconazole (even at suprapharmacological
concentrations within the mg/ml range) did not have any
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FIGURE 5 | Inhibition of biofilm formation in single- and dual species C. albicans/S. gordonii biofilms formed in 1:1 v/v RPMI/ THB + 0.02% YE media
(upper panels A,B) or BMM synthetic saliva (BMM, lower panels A,B) by monotherapy (A) and by antibacterial/antifungal combination therapy (B).
Drugs concentrations were as follows: Clindamycin at 100, 10, 1, 0.1, 0.01 µM; Fluconazole at 0.5, 0.25, 0.125, 0.0625, and 0.03125 mg/ml; Amphotericin B at 16,
4, 1, 0.25, 0.0625 µg/ml, and Caspofungin at 16, 8, 4, 2, 1 µg/ml.
effect on pre-formed C. albicans biofilms as previously reported
(Ramage et al., 2001; Pierce et al., 2015; Figure 6A). In
the case of S. gordonii, we observed increased resistance of
the preformed bacterial biofilms against monotherapy with
clindamycin as compared to the results for inhibition of biofilm
formation (compare Figures 5A and 6A); although treatment
with clindamycin was more effective against biofilms grown in
BMM synthetic saliva (Figure 6A). Mixed biofilms, as expected,
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demonstrated high levels of resistance to all of the drugs when
used in monotherapy (Figure 6A). Supplementary Table S2
summarizes the resulting SMIC50 and SMIC80 values for each
drug tested in monotherapy experiments against both single-
and dual-species preformed biofilms. We then assayed the
three previously tested antifungals (fluconazole, amphotericin
B, and caspofungin) in combination with clindamycin at
various concentrations against preformed dual species biofilms
of C. albicans/S. gordonii in both 1:1 media and BMM synthetic
saliva. As shown in Figure 6B, these preformed mixed biofilms
are particularly recalcitrant to antimicrobial therapy, irrespective
of the media used. The combination of fluconazole and
clindamycin proved ineffectual against these bacterial/fungal
biofilms. The combinations of clindamycin (at 1, 10, and
100 µM) and either Amphotericin B (at high concentrations), or
caspofungin (at lower/physiological concentrations) were able to
reduce the metabolic activity in preformed mixed biofilms by 40–
50%. Again, these results confirm the higher resistance exhibited
by preformed biofilms and most importantly the difficulties in
treating established mixed fungal/bacterial biofilms, even when
using combinatorial therapy.
DISCUSSION
Similar to other members of the oral human microbiota,
C. albicans is able to adapt, live and thrive under the
environmental conditions encountered within the oral cavity,
where biofilm formation constitutes a major contributing factor
to its success as a commensal and opportunistic pathogen
(Gendreau and Loewy, 2011; O’Donnell et al., 2015b). Biofilm
formation renders fungal cells inaccessible and resistant to
antimicrobial treatment and provides protection against the
host’s immune system, and as such the impact of complications
caused by biofilms on patient care and well-being emphasizes the
significance of this study (Pierce et al., 2013, 2015).
Candida albicans has the capacity to interact with surrounding
bacteria of the human microbiota, occasionally supporting their
growth and survival within human tissues (Cramer, 2014; Fox
et al., 2014; O’Donnell et al., 2015a), although our current
understanding of this phenomenon is limited by the many
bacterial species found in the human microbiome that C. albicans
encounters during and after colonization (O’Donnell et al.,
2015a,b). In recent years the ability of C. albicans to interact
and form mixed species biofilms with members of the oral
bacterial microbiota has received increased attention (reviewed in
Shirtliff et al., 2009; O’Donnell et al., 2015a). C. albicans-bacterial
cross-kingdom interactions with important clinical repercussions
include those with methicillin-resistant Staphylococcus aureus
(MRSA) and Pseudomonas aeruginosa, which have been shown
to communicate with C. albicans within a mixed biofilm
microenvironment (Hogan et al., 2004; Harriott and Noverr,
2009; Shirtliff et al., 2009; Peleg et al., 2010; Mear et al., 2013;
O’Donnell et al., 2015a; Zago et al., 2015). Most recently, (Fox
et al., 2014) demonstrated that C. albicans is able to produce
hypoxic microenvironments within a biofilm to facilitate the
growth of anaerobic bacteria such as Clostridium perfringens.
It has been reported that under certain circumstances,
C. albicans virulence can be enhanced by the presence of
oral bacteria that may induce the up-regulation of hyphal-
specific genes and other virulence-related genes leading to
biofilm formation along with the production of secretyl-
aspartic proteinases (SAPs), exopolymeric matrix components
and adhesins that can contribute to filamentation, colonization
and invasive infection (Hawser et al., 1998; Baillie and Douglas,
2000; Diaz et al., 2014; Cavalcanti et al., 2015). In particular,
the interactions between C. albicans and S. gordonii, a gram-
positive bacterium that prevails in dental plaque (Marsh et al.,
2011), are among the best studied, and the focus of this
study. As an early colonizer of the oral mucosa, S. gordonii is
thought to aid C. albicans by providing an adherent surface
that further facilitates colonization of oral tissues by C. albicans,
often resulting in the formation of mixed oral Candida–
Streptococcus biofilms (Bamford et al., 2009; Diaz et al., 2012; Xu
et al., 2014). This interesting relationship suggests intergeneric
communication that may involve adhesin-receptor interactions
such as bacterial adhesins SspA and SspB with hyphal cell
wall receptor Als3p, as well as secretion and/or modulation of
quorum sensing molecules, which together lead to synergism
for survival as mixed species biofilms (Diaz et al., 2012). For
example, Bamford et al. (2009) showed that S. gordonii is
able to modulate C. albicans biofilm formation by preventing
proper detection of farnesol by the fungus. This has important
implications for pathogenicity, as farnesol is a quorum sensor
normally produced by C. albicans, which functions as a self-
restriction signal to limit biofilm expansion when cells have
colonized a surface. Thus, inhibition of farnesol detection leads
to production of more robust biofilms, increasing pathogenicity
effects and antimicrobial resistance (Hornby et al., 2001; Ramage
et al., 2002; Bamford et al., 2009; Lindsay et al., 2012).
Taken into consideration the above-mentioned aspects of oral
mixed biofilms, in this study we have developed an in vitro model
of dual-species S. gordonii and C. albicans biofilms in 96-well
microtiter plate using a physiologically relevant medium of the
buccal environment such as BMM synthetic saliva, a medium
rich in peptone and yeast extract that was designed to grow
oral plaque biofilms (Wong and Sissons, 2001; Sissons et al.,
2007), and which closely mimics conditions that microorganisms
encounter within the oral microenvironment. We believe this is
a good saliva analog as it clearly allows C. albicans to filament
in our in vitro model unlike other synthetic alternatives that
do not seem to induce fungal filamentation at 37◦C (Arzmi
et al., 2015). This is in contrast with previous models that
use traditional, nutrient-rich microbiological media, which have
been optimized for growth of either bacteria or fungi. We
grew single and dual-species (C. albicans/S. gordonii) biofilms in
96-well microtiter plates using BMM synthetic saliva medium
or traditional microbiological normally used to grow fungal
or bacterial biofilms. For estimation of the extent of biofilm
formation we used Presto BlueTM which is able to measure
metabolic activity of both fungal and bacterial cells (Deepe and
Buesing, 2012; Potapova et al., 2013). Our results indicate that
BMM synthetic saliva is able to support growth of monospecies
biofilms of C. albicans, and to a lesser extent S. gordonii,
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FIGURE 6 | Antimicrobial susceptibility patterns of preformed single- and dual species C. albicans/S. gordonii biofilms formed in 1:1 v/v RPMI/ THB
+ 0.02% YE media (upper panels A,B) or BMM synthetic saliva (BMM, lower panels A,B) using monotherapy (A) and antibacterial/antifungal
combination therapy (B). Drugs concentrations were as follows: Clindamycin at 100, 10, 1, 0.1, 0.01 µM; Fluconazole at 1, 0.5, 0.25, 0.125, 0.0625 mg/ml;
Amphotericin B at 16, 4, 1, 0.25, 0.0625 µg/ml, and Caspofungin at 16, 8, 4, 2, 1 µg/ml.
although the resulting biofilms are less robust (less metabolically
active) than those formed using traditional microbiological
media optimized for growth of fungi or bacteria (Figures 1 and
2, also Supplementary Figure S1). But perhaps more interesting
is the fact that a synergistic effect was clearly manifested
in the case of the dual species biofilms formed using the
more nutrient-limited synthetic saliva medium, pointing to the
existence of beneficial, mutualistic cross-kingdom interactions,
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as previously reported using different media (Shirtliff et al.,
2009). SEM and CSLM provided additional insights into the
morphological, structural and architectural characteristics of the
resulting biofilms (Figures 3 and 4, also Supplementary Figures
S2 and S3). The implementation of these advanced microscopy
techniques revealed a few notable distinct features of biofilms
formed using BMM synthetic saliva as compared to those formed
traditional microbiological media. S. gordonii biofilms formed
in synthetic saliva are composed of long streptococcal chains,
as compared to densely packed cellular aggregates observed in
biofilms formed using 1:1 media (Figure 3). However in the
case of mixed species biofilms, and irrespective of morphology,
streptococci were found to bind primary to C. albicans hyphae
within the biofilms, also in agreement with previous reports
(Bamford et al., 2009; Silverman et al., 2010; Figure 3). CSLM
observations corroborated the fact that both media conditions
allowed for the formation of mixed biofilms with good cell
density. Interestingly, despite lower metabolic readings, mixed
biofilms in BMM synthetic saliva display thicker cross-sections
and higher biovolume as compared to those formed in traditional
microbiological media (Figure 4), Moreover CSLM also revealed
the higher production of exopolymeric matrix in single species
biofilms formed using BMM saliva, although this was not the case
in mixed species biofilms.
One of the salient features of biofilms is their increased
resistance to antimicrobial treatment, and this problem is further
aggravated by the formation of polymicrobial biofilms, with
negative clinical repercussions (Haffajee and Socransky, 2001;
Lana et al., 2001; Jenkinson and Douglas, 2002; Chukkapalli
et al., 2015). Thus, in this study we wanted to examine the
resistance properties of biofilms formed in BMM synthetic saliva
in comparison to those formed using traditional microbiological
media. Our experimental design included the use of monotherapy
and combination therapy (antibacterial plus antifungal) against
both single- and dual-species biofilms, and two different
regimens: one looking at inhibition of biofilm formation and
another one at activity against preformed biofilms. Results from
these series of experiments confirmed the overall decreased
susceptibility of biofilms to antimicrobial treatment, with similar
susceptibility patterns observed for biofilms formed using
synthetic saliva as opposed to traditional microbiological media.
In agreement with previous reports (Jenkinson and Douglas,
2002; Harriott and Noverr, 2009; Peters et al., 2012), results
also provided confirmation of the increased resistance of mixed
C. albicans/S. gordonii biofilms as compared to single species
biofilms. Thus, for mixed fungal/bacterial biofilms, these results
point to the difficulties in preventing biofilm development as well
as in treating established biofilms.
Although, more studies are required to unravel the complexity
of mixed biofilms, we expect that this model can serve as a
platform for further analyses of complex polymicrobial biofilms
under growth conditions that more closely resemble those
encountered within the oral cavity, and can also be applied to
high-content screening of new drug candidates against mixed
species biofilms that are urgently needed.
AUTHOR CONTRIBUTIONS
DM-J conducted the experiments, wrote the manuscript and
analyzed the data. AR contributed to the data analysis. AS
and JL-R conceived the study, contributed to data analysis and
preparation of the manuscript. All authors read and approved the
manuscript for submission.
FUNDING
Biofilm-related work in the laboratory is supported by grants
numbered R01DE023510 and R01AI119554 from the National
Institute of Dental and Craniofacial Research and the National
Institute of Allergy and Infectious Diseases, respectively to JL-R.
Additional support was provided by the Army Research Office
of the Department of Defense under Contract No. W911NF-11-
1-0136 (to JL-R) and by the Margaret Batts Tobin Foundation,
San Antonio, TX, USA. Confocal microscopy was performed
at the RCMI Advance Imaging Center, with computational
support from Computational System Biology Core, funded by
the National Institute on Minority Health and Health Disparities
(G12MD007591). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the
manuscript, and the content is solely the responsibility of the
authors.
ACKNOWLEDGMENT
We thank Dr. Kendra Rumbaugh from TTUHSC for kindly
providing S. gordonii wild-type strain Challis DL1.1.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.00686
REFERENCES
Arslan, S. G., Akpolat, N., Kama, J. D., Ozer, T., and Hamamci, O. (2008). One-year
follow-up of the effect of fixed orthodontic treatment on colonization by oral
Candida. J. Oral Pathol. Med. 37, 26–29. doi: 10.1111/j.1600-0714.2007.00574.x
Arzmi, M. H., Dashper, S., Catmull, D., Cirillo, N., Reynolds, E. C., and
McCullough, M. (2015). Coaggregation of Candida albicans, Actinomyces
naeslundii and Streptococcus mutans is Candida albicans strain dependent.
FEMS Yeast Res. 15:fov038. doi: 10.1093/femsyr/fov038
Baillie, G. S., and Douglas, L. J. (2000). Matrix polymers of Candida biofilms and
their possible role in biofilm resistance to antifungal agents. J. Antimicrob.
Chemother. 46, 397–403. doi: 10.1093/jac/46.3.397
Bamford, C. V., d’Mello, A., Nobbs, A. H., Dutton, L. C., Vickerman, M. M., and
Jenkinson, H. F. (2009). Streptococcus gordonii modulates Candida albicans
Frontiers in Microbiology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 686
fmicb-07-00686 May 12, 2016 Time: 14:57 # 12
Montelongo-Jauregui et al. Mixed Biofilms on Synthetic Saliva
biofilm formation through intergeneric communication. Infect. Immun. 77,
3696–3704. doi: 10.1128/IAI.00438-09
Cavalcanti, Y. W., Morse, D. J., da Silva, W. J., Del-Bel-Cury, A. A., Wei, X.,
Wilson, M., et al. (2015). Virulence and pathogenicity of Candida albicans
is enhanced in biofilms containing oral bacteria. Biofouling 31, 27–38. doi:
10.1080/08927014.2014.996143
Chukkapalli, S. S., Velsko, I. M., Rivera-Kweh, M. F., Zheng, D., Lucas, A. R., and
Kesavalu, L. (2015). Polymicrobial oral infection with four periodontal bacteria
orchestrates a distinct inflammatory response and atherosclerosis in apoenull
mice. PLoS ONE 10:e0143291. doi: 10.1371/journal.pone.0143291
Cramer, R. A. (2014). Biofilms: five-star accommodations for the aerobically
challenged. Curr Biol. 24, R1002–R1004. doi: 10.1016/j.cub.2014.09.030
Cugini, C., Morales, D. K., and Hogan, D. A. (2010). Candida albicans-
produced farnesol stimulates Pseudomonas quinolone signal production in
LasR-defective Pseudomonas aeruginosa strains. Microbiology 156, 3096–3107.
doi: 10.1099/mic.0.037911-0
de Carvalho, F. G., Silva, D. S., Hebling, J., Spolidorio, L. C., and Spolidorio,
D. M. (2006). Presence of mutans streptococci and Candida spp. in dental
plaque/dentine of carious teeth and early childhood caries. Arch. Oral. Biol. 51,
1024–1028. doi: 10.1016/j.archoralbio.2006.06.001
Deepe, G. S. Jr., and Buesing, W. R. (2012). Deciphering the pathways of
death of Histoplasma capsulatum-infected macrophages: implications for
the immunopathogenesis of early infection. J. Immunol. 188, 334–344. doi:
10.4049/jimmunol.1102175
Diaz, P. I., Strausbaugh, L. D., and Dongari-Bagtzoglou, A. (2014). Fungal-bacterial
interactions and their relevance to oral health: linking the clinic and the bench.
Front. Cell Infect. Microbiol. 4:101. doi: 10.3389/fcimb.2014.00101
Diaz, P. I., Xie, Z., Sobue, T., Thompson, A., Biyikoglu, B., Ricker, A., et al.
(2012). Synergistic interaction between Candida albicans and commensal oral
streptococci in a novel in vitro mucosal model. Infect. Immun. 80, 620–632. doi:
10.1128/IAI.05896-11
Dongari-Bagtzoglou, A., Kashleva, H., Dwivedi, P., Diaz, P., and Vasilakos, J.
(2009). Characterization of mucosal Candida albicans biofilms. PLoS ONE
4:e7967. doi: 10.1371/journal.pone.0007967
Falsetta, M. L., Klein, M. I., Colonne, P. M., Scott-Anne, K., Gregoire, S., Pai,
C. H., et al. (2014). Symbiotic relationship between Streptococcus mutans and
Candida albicans synergizes virulence of plaque biofilms in vivo. Infect. Immun.
82, 1968–1981. doi: 10.1128/IAI.00087-14
Filkins, L. M., Graber, J. A., Olson, D. G., Dolben, E. L., Lynd, L. R., Bhuju, S.,
et al. (2015). Coculture of Staphylococcus aureus with Pseudomonas aeruginosa
Drives S. aureus towards fermentative metabolism and reduced viability in a
cystic fibrosis model. J. Bacteriol. 197, 2252–2264. doi: 10.1128/JB.00059-15
Fox, E. P., Cowley, E. S., Nobile, C. J., Hartooni, N., Newman, D. K., and Johnson,
A. D. (2014). Anaerobic bacteria grow within Candida albicans biofilms and
induce biofilm formation in suspension cultures. Curr. Biol. 24, 2411–2416. doi:
10.1016/j.cub.2014.08.057
Freitas, A. O., Marquezan, M., Nojima Mda, C., Alviano, D. S., and Maia, L. C.
(2014). The influence of orthodontic fixed appliances on the oral microbiota:
a systematic review. Dental Press J. Orthod. 19, 46–55. doi: 10.1590/2176-
9451.19.2.046-055.oar
Gendreau, L., and Loewy, Z. G. (2011). Epidemiology and etiology of
denture stomatitis. J. Prosthodont. 20, 251–260. doi: 10.1111/j.1532-849X.2011.
00698.x
Haffajee, A. D., and Socransky, S. S. (2001). Relationship of cigarette smoking to the
subgingival microbiota. J. Clin. Periodontol. 28, 377–388. doi: 10.1034/j.1600-
051x.2001.028004283.x
Harriott, M. M., and Noverr, M. C. (2009). Candida albicans and Staphylococcus
aureus form polymicrobial biofilms: effects on antimicrobial resistance.
Antimicrob. Agents Chemother. 53, 3914–3922. doi: 10.1128/AAC.00657-09
Hawser, S. P., Baillie, G. S., and Douglas, L. J. (1998). Production of extracellular
matrix by Candida albicans biofilms. J. Med. Microbiol. 47, 253–256. doi:
10.1099/00222615-47-3-253
Hawser, S. P., and Douglas, L. J. (1995). Resistance of Candida albicans biofilms to
antifungal agents in vitro. Antimicrob. Agents Chemother. 39, 2128–2131. doi:
10.1128/AAC.39.9.2128
Hogan, D. A., Vik, A., and Kolter, R. (2004). A Pseudomonas aeruginosa quorum-
sensing molecule influences Candida albicans morphology. Mol. Microbiol. 54,
1212–1223. doi: 10.1111/j.1365-2958.2004.04349.x
Holmes, A. R., Gopal, P. K., and Jenkinson, H. F. (1995). Adherence of Candida
albicans to a cell surface polysaccharide receptor on Streptococcus gordonii.
Infect. Immun. 63, 1827–1834.
Holmes, A. R., van der Wielen, P., Cannon, R. D., Ruske, D., and Dawes, P. (2006).
Candida albicans binds to saliva proteins selectively adsorbed to silicone.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102, 488–494. doi:
10.1016/j.tripleo.2005.10.052
Hornby, J. M., Jensen, E. C., Lisec, A. D., Tasto, J. J., Jahnke, B., Shoemaker, R.,
et al. (2001). Quorum sensing in the dimorphic fungus Candida albicans
is mediated by farnesol. Appl. Environ. Microbiol. 67, 2982–2992. doi:
10.1128/AEM.67.7.2982-2992.2001
Hwang, G., Marsh, G., Gao, L., Waugh, R., and Koo, H. (2015). Binding force
dynamics of Streptococcus mutans-glucosyltransferase B to Candida albicans.
J. Dent. Res. 94, 1310–1317. doi: 10.1177/0022034515592859
Ishijima, S. A., Hayama, K., Burton, J. P., Reid, G., Okada, M., Matsushita, Y., et al.
(2012). Effect of Streptococcus salivarius K12 on the in vitro growth of Candida
albicans and its protective effect in an oral candidiasis model. Appl. Environ.
Microbiol. 78, 2190–2199. doi: 10.1128/AEM.07055-11
Jakubovics, N. S. (2015). Intermicrobial interactions as a driver for community
composition and stratification of oral biofilms. J. Mol. Biol. 427, 3662–3675. doi:
10.1016/j.jmb.2015.09.022
Jakubovics, N. S., Yassin, S. A., and Rickard, A. H. (2014). Community interactions
of oral streptococci. Adv. Appl. Microbiol. 87, 43–110. doi: 10.1016/B978-0-12-
800261-2.00002-5
Jarosz, L. M., Deng, D. M., van der Mei, H. C., Crielaard, W., and Krom,
B. P. (2009). Streptococcus mutans competence-stimulating peptide inhibits
Candida albicans hypha formation. Eukaryot. Cell 8, 1658–1664. doi:
10.1128/EC.00070-09
Jenkinson, H. F., and Douglas, L. J. (2002). “Interactions between Candida species
and bacteria in mixed infections,” in Polymicrobial Diseases, eds K. A. Brogden
and J. M. Guthmiller (Washington, DC: ASM Press).
Jenkinson, H. F., Lala, H. C., and Shepherd, M. G. (1990). Coaggregation of
Streptococcus sanguis and other streptococci with Candida albicans. Infect.
Immun. 58, 1429–1436.
Lana, M. A., Ribeiro-Sobrinho, A. P., Stehling, R., Garcia, G. D., Silva,
B. K., Hamdan, J. S., et al. (2001). Microorganisms isolated from root
canals presenting necrotic pulp and their drug susceptibility in vitro.
Oral. Microbiol. Immunol. 16, 100–105. doi: 10.1034/j.1399-302x.2001.016
002100.x
Lindsay, A. K., Deveau, A., Piispanen, A. E., and Hogan, D. A. (2012). Farnesol
and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida
albicans. Eukaryot. Cell 11, 1219–1225. doi: 10.1128/EC.00144-12
Loo, C. Y., Corliss, D. A., and Ganeshkumar, N. (2000). Streptococcus gordonii
biofilm formation: identification of genes that code for biofilm phenotypes.
J. Bacteriol. 182, 1374–1382. doi: 10.1128/JB.182.5.1374-1382.2000
Marsh, P. D., Moter, A., and Devine, D. A. (2011). Dental plaque biofilms:
communities, conflict and control. Periodontology 55, 16–35. doi:
10.1111/j.1600-0757.2009.00339.x
Mathe, L., and Van Dijck, P. (2013). Recent insights into Candida albicans biofilm
resistance mechanisms. Curr. Genet. 59, 251–264. doi: 10.1007/s00294-013-
0400-3
Mear, J. B., Kipnis, E., Faure, E., Dessein, R., Schurtz, G., Faure, K., et al.
(2013). Candida albicans and Pseudomonas aeruginosa interactions: more than
an opportunistic criminal association? Med. Mal Infect. 43, 146–151. doi:
10.1016/j.medmal.2013.02.005
Meurman, J. H., and Hamalainen, P. (2006). Oral health and morbidity–
implications of oral infections on the elderly. Gerodontology 23, 3–16. doi:
10.1111/j.1741-2358.2006.00102.x
Morales, D. K., and Hogan, D. A. (2010). Candida albicans interactions with
bacteria in the context of human health and disease. PLoS Pathog. 6:e1000886.
doi: 10.1371/journal.ppat.1000886
Muzyka, B. C. (2005). Oral fungal infections. Dent. Clin. North. Am. 49, 49–65. doi:
10.1016/j.cden.2004.07.007
Muzyka, B. C., and Epifanio, R. N. (2013). Update on oral fungal infections. Dent.
Clin. North. Am. 57, 561–581. doi: 10.1016/j.cden.2013.07.002
O’Donnell, L. E., Millhouse, E., Sherry, L., Kean, R., Malcolm, J., Nile, C. J., et al.
(2015a). Polymicrobial Candida biofilms: friends and foe in the oral cavity.
FEMS Yeast Res. 15:fov077. doi: 10.1093/femsyr/fov077
Frontiers in Microbiology | www.frontiersin.org 12 May 2016 | Volume 7 | Article 686
fmicb-07-00686 May 12, 2016 Time: 14:57 # 13
Montelongo-Jauregui et al. Mixed Biofilms on Synthetic Saliva
O’Donnell, L. E., Robertson, D., Nile, C. J., Cross, L. J., Riggio, M., Sherriff, A.,
et al. (2015b). The oral microbiome of denture wearers is influenced by levels of
natural dentition. PLoS ONE 10:e0137717. doi: 10.1371/journal.pone.0137717
O’Sullivan, J. M., Jenkinson, H. F., and Cannon, R. D. (2000). Adhesion of Candida
albicans to oral streptococci is promoted by selective adsorption of salivary
proteins to the streptococcal cell surface. Microbiology 146(Pt 1), 41–48. doi:
10.1099/00221287-146-1-41
Parks, T., Barrett, L., and Jones, N. (2015). Invasive streptococcal disease: a review
for clinicians. Br. Med. Bull. 115, 77–89. doi: 10.1093/bmb/ldv027
Peleg, A. Y., Hogan, D. A., and Mylonakis, E. (2010). Medically important
bacterial-fungal interactions. Nat. Rev. Microbiol. 8, 340–349. doi:
10.1038/nrmicro2313
Peters, B. M., Jabra-Rizk, M. A., O’May, G. A., Costerton, J. W., and Shirtliff, M. E.
(2012). Polymicrobial interactions: impact on pathogenesis and human disease.
Clin. Microbiol. Rev. 25, 193–213. doi: 10.1128/CMR.00013-11
Pfaller, M. A. (2012). Antifungal drug resistance: mechanisms, epidemiology,
and consequences for treatment. Am. J. Med. 125, S3–S13. doi:
10.1016/j.amjmed.2011.11.001
Pierce, C. G., Srinivasan, A., Ramasubramanian, A. K., and Lopez-Ribot, J. L.
(2015). From biology to drug development: new approaches to combat the
threat of fungal biofilms. Microbiol. Spectr. 3. doi: 10.1128/microbiolspec.MB-
0007-2014
Pierce, C. G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A. K., and Lopez-
Ribot, J. L. (2013). Antifungal therapy with an emphasis on biofilms. Curr. Opin.
Pharmacol. 13, 726–730. doi: 10.1016/j.coph.2013.08.008
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L. Jr., Mowat, E., Ramage, G.,
et al. (2008). A simple and reproducible 96-well plate-based method for the
formation of fungal biofilms and its application to antifungal susceptibility
testing. Nat. Protoc. 3, 1494–1500. doi: 10.1038/nport.2008.141
Potapova, I., Eglin, D., Laschke, M. W., Bischoff, M., Richards, R. G., and Moriarty,
T. F. (2013). Two-step labeling of Staphylococcus aureus with Lysostaphin-
Azide and DIBO-Alexa using click chemistry. J. Microbiol. Methods 92, 90–98.
doi: 10.1016/j.mimet.2012.11.004
Ramage, G., Saville, S. P., Wickes, B. L., and Lopez-Ribot, J. L. (2002). Inhibition of
Candida albicans biofilm formation by farnesol, a quorum-sensing molecule.
Appl. Environ. Microbiol. 68, 5459–5463. doi: 10.1128/AEM.68.11.5459-
5463.2002
Ramage, G., Tomsett, K., Wickes, B. L., Lopez-Ribot, J. L., and Redding, S. W.
(2004). Denture stomatitis: a role for Candida biofilms. Oral Surg. Oral Med.
Oral Pathol. Oral Radiol. Endod. 98, 53–59. doi: 10.1016/S1079210404002872
Ramage, G., Vandewalle, K., Wickes, B. L., and Lopez-Ribot, J. L. (2001).
Characteristics of biofilm formation by Candida albicans. Rev. Iberoam Micol.
18, 163–170.
Sardi, J. C., Duque, C., Mariano, F. S., Peixoto, I. T., Hofling, J. F., and Goncalves,
R. B. (2010). Candida spp. in periodontal disease: a brief review. J. Oral. Sci. 52,
177–185. doi: 10.2334/josnusd.52.177
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T.,
et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat.
Methods 9, 676–682. doi: 10.1038/nmeth.2019
Shirtliff, M. E., Peters, B. M., and Jabra-Rizk, M. A. (2009). Cross-kingdom
interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 299, 1–8. doi:
10.1111/j.1574-6968.2009.01668.x
Silverman, R. J., Nobbs, A. H., Vickerman, M. M., Barbour, M. E., and Jenkinson,
H. F. (2010). Interaction of Candida albicans cell wall Als3 protein with
Streptococcus gordonii SspB adhesin promotes development of mixed-species
communities. Infect. Immun. 78, 4644–4652. doi: 10.1128/IAI.00685-10
Sissons, C. H., Anderson, S. A., Wong, L., Coleman, M. J., and White, D. C. (2007).
Microbiota of plaque microcosm biofilms: effect of three times daily sucrose
pulses in different simulated oral environments. Caries Res. 41, 413–422. doi:
10.1159/000104801
Waltimo, T. M., Siren, E. K., Torkko, H. L., Olsen, I., and Haapasalo, M. P. (1997).
Fungi in therapy-resistant apical periodontitis. Int. Endod J. 30, 96–101. doi:
10.1111/j.1365-2591.1997.tb00681.x
Williams, D. W., Kuriyama, T., Silva, S., Malic, S., and Lewis, M. A. (2011). Candida
biofilms and oral candidosis: treatment and prevention. Periodontology 55,
250–265. doi: 10.1111/j.1600-0757.2009.00338.x
Wong, L., and Sissons, C. (2001). A comparison of human dental plaque
microcosm biofilms grown in an undefined medium and a chemically
defined artificial saliva. Arch. Oral. Biol. 46, 477–486. doi: 10.1016/S0003-
9969(01)00016-4
Wu, T., Cen, L., Kaplan, C., Zhou, X., Lux, R., Shi, W., et al. (2015). Cellular
components mediating coadherence of Candida albicans and Fusobacterium
nucleatum. J. Dent. Res. 94, 1432–1438. doi: 10.1177/0022034515593706
Xu, H., Jenkinson, H. F., and Dongari-Bagtzoglou, A. (2014). Innocent until proven
guilty: mechanisms and roles of Streptococcus-Candida interactions in oral
health and disease. Mol. Oral. Microbiol. 29, 99–116. doi: 10.1111/omi.12049
Zago, C. E., Silva, S., Sanita, P. V., Barbugli, P. A., Dias, C. M., Lordello, V. B., et al.
(2015). Dynamics of biofilm formation and the interaction between Candida
albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus
aureus (MRSA). PLoS ONE 10:e0123206. doi: 10.1371/journal.pone.0123206
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Montelongo-Jauregui, Srinivasan, Ramasubramanian and Lopez-
Ribot. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) or licensor are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 13 May 2016 | Volume 7 | Article 686
